This cannabis company brings more than 40 years of experience to the industry. You’re really playing Russian roulette with your health with some of the products that were out there and being used. And so what we’ve done is we’ve taken the guesswork out and it’s absolutely standardized to an exact milligram for dosage. Quality in, quality out is really what it comes down to.
At CannTrust™ we are committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive Pharma partner Apotex are diligently innovating and developing products that will make it easier for patients to use Medical Cannabis today and in the future. We support ongoing patient education about Medical Cannabis, and have launched a compassionate use program to support patients with financial needs.
Our 50,000-square foot state-of-the-art hydroponic facility provides pharmaceutical grade control and results, combined with a patient-centric focus, ensures we are producing quality products and delivering superior service to our customers.
To satisfy the demand for our products, we are expanding our production capacity with a 430,000-square foot greenhouse in the heart of the Niagara region. The facility has been designed and engineered to ensure our customers have a continuous supply of high quality, standardized products. This facility will be the first of its kind in Canada, one of the largest in North America, and the first phase will come on-stream in fall 2017.
For more information on CannTrust (TRST.CN) please fill out the form below.